Thursday – May 28, 2009 1:45 pm – 3:00 pm George Stamatoyannopoulos Lecture
Brian J. Druker, MD, Director, Oregon Health and Science University Knight Cancer Institute Imatinib as a Paradigm of Molecularly Targeted Cancer Therapies
Friday – May 29, 2009 8:00 am – 9:15 am Outstanding Achievement Award
Inder Verma, PhD, American Cancer Society Professor of Molecular Biology, The Salk Institute 25 Years of Gene Therapy: Ups and Downs
John Carpten, PhD, Senior Investigator & Director, the Translational Genomics Research Institute (T-Gen) Interrogation of Cancer Genomes for the Discovery of Novel Therapeutic Targets
John J. Nemunaitis, MD, Executive Director, Mary Crowley Medical Research Center Personalized Cancer Gene Therapy
Helen E. Heslop, MD, Professor, Department of Pediatrics and Medicine at the Baylor College of Medicine Immunotherapy of Viral Infections and Malignancy
Chiara Bonini, MD, Cancer Immunotherapy and Gene Therapy Program, Fondazione Centro S. Raffaele
Del Monte Tabor T-cell Based Gene Therapy to Improve Hematopoietic Stem Cell Transplantation
Membership
